November 30, 2016

Alexandria, Va. – CancerLinQ LLC, a nonprofit subsidiary of the American Society of Clinical Oncology® (ASCO), today announced CancerLinQ Discovery™, a groundbreaking offering that will provide insights through the analysis of real-world cancer care data. CancerLinQ Discovery will provide highly curated, de-identified sets of clinical data with the objective of creating new clinical knowledge and improving patient outcomes. It will derive these sets from the rapidly-growing CancerLinQ® database, which now includes over 1.5 million patient records and more than 70 oncology practices that have agreed to contribute data to CancerLinQ’s core quality improvement and data-sharing platform.

November 16, 2016

More than 100 participants are now enrolled on study drug in the American Society of Clinical Oncology’s (ASCO®) Targeted Agent and Profiling Utilization Registry (TAPUR) Study. The trial launched in March 2016 at 37 sites and this month welcomes its newest participating clinical sites: Cancer Treatment Centers of America®, Intermountain Healthcare, Sanford Health, Swedish Cancer Institute and Providence Health & Services, and University of Nebraska Medical Center for a total of 63 participating sites in 15 states.

November 15, 2016

ALEXANDRIA, VA – A new collaboration between the American Society of Clinical Oncology (ASCO) and the American Board of Internal Medicine (ABIM) will enable participants of ASCO’s Quality Oncology Practice Initiative (QOPI®) and the QOPI Certification Program (QCP) to receive Maintenance of Certification (MOC) Practice Assessment points from ABIM.

October 20, 2016

ALEXANDRIA, Va. – CancerLinQ LLC, a wholly-owned nonprofit of the American Society of Clinical Oncology (ASCO), announced today that more than one million patient records are now in the CancerLinQ™ platform. In addition, 70 practices have signed agreements to participate in CancerLinQ, representing more than 1,500 oncologists.

October 10, 2016

ALEXANDRIA, Va. – CancerLinQ LLC (CLQ LLC) CEO Kevin Fitzpatrick has been appointed to the Cancer Informatics for Cancer Centers (CI4CC) Corporate Advisory Board. CancerLinQ LLC is a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology, Inc. (ASCO®) and Mr. Fitzpatrick’s appointment builds on CI4CC and CLQ LLC’s collaborative efforts to help improve cancer care.

June 27, 2016

The American Society of Clinical Oncology (ASCO) and CancerLinQ LLC will join Vice President Joe Biden and other leaders in the cancer community for the Cancer Moonshot Summit at Howard University, on June 29, to launch new collaborations and exchange ideas on solving the complexities of cancer care.

June 1, 2016

American Society of Clinical Oncology, Inc. (ASCO®) announced today that the Contemporary Oncology Team of Athens, Greece as part of the new international pilot project, is the first international practice to receive  Quality Oncology Practice Initiative (QOPI®) certification through  QOPI Certification Program, LLC (QCP).

January 29, 2015

CHICAGO – The American Society of Clinical Oncology’s (ASCO) wholly owned non-profit subsidiary, CancerLinQ LLC, will provide the first demonstration of its groundbreaking health information technology (HIT) platform at ASCO’s 51st Annual Meeting.  

September 17, 2014

The American Society of Clinical Oncology (ASCO) today announced the “Top 5 Advances in 50 Years of Modern Oncology,” based on results of worldwide voting on CancerProgress.Net – ASCO’s interactive website documenting the history of progress against cancer.

March 24, 2014

ALEXANDRIA, VA -- The American Society of Clinical Oncology (ASCO) has issued new recommendations for the use of sentinel lymph node biopsy in patients with early stage breast cancer. The guideline, "Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update," was published today in the Journal of Clinical Oncology.

Pages